Skip to main content

Find Clinical Trials

Home
Conditions
Huntington Disease

Clinical trial condition

Huntington Disease

Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.

226 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Huntington Disease trial results

Completed

Memory Disorders Registry

NCT00654563

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +24 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

Riluzole in Huntington's Disease

NCT00277602

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

NCT01521832

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Covance Clinical Research Unit Leeds, United Kingdom

View Trial Details

Completed

Effects of Music Therapy on Huntington's Disease

NCT00178360

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

NCT00825084

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
Locations: Pfizer Investigational Site Glendale, California, United States

View Trial Details

Completed

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
Locations: Pfizer Investigational Site Kalamazoo, Michigan, United States

View Trial Details

Completed

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

NCT00988624

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
Locations: Pfizer Investigational Site New Haven, Connecticut, United States

View Trial Details

Completed

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

NCT00824590

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +24 more
Locations: Pfizer Investigational Site Miami, Florida, United States

Pfizer Investigational Site Saint Paul, Minnesota, United States

View Trial Details

Completed

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

NCT00931073

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
Locations: Pfizer Investigational Site Kalamazoo, Michigan, United States

View Trial Details

Completed

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects

NCT00831506

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
Locations: Pfizer Investigational Site New Haven, Connecticut, United States

View Trial Details